COVID vaccine tech tested as potential reset for stubborn immune diseases
NCT ID NCT07388212
Summary
This early study is testing a new type of drug that uses mRNA technology (like some COVID-19 vaccines) to treat autoimmune diseases that have come back or not responded to other treatments. It aims to find a safe dose by giving the drug to about 27 adults with conditions like lupus. The drug is designed to target and remove specific immune cells that cause the body to attack itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.